Sign In
Buy MDT
$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
08:09am, Monday, 29'th Sep 2025
GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of
Medtronic (MDT) Suffers a Larger Drop Than the General Market: Key Insights
06:51pm, Thursday, 25'th Sep 2025
In the closing of the recent trading day, Medtronic (MDT) stood at $94.3, denoting a -1.5% move from the preceding trading day.
Here's Why Medtronic (MDT) is a Strong Value Stock
10:41am, Thursday, 25'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Federated Hermes launches Federated Hermes MDT Market Neutral ETF
08:32am, Thursday, 25'th Sep 2025
New product leverages MDT investment team's three decades of experience and skill PITTSBURGH , Sept. 25, 2025 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing,
Medtronic: FY26 Outlook Strengthened By New Product Launches
08:13am, Thursday, 25'th Sep 2025
Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d
The Ultimate High Yield Healthcare Stock to Buy With $10,000 Right Now
07:20am, Thursday, 25'th Sep 2025
Technological advances are a key driver in the healthcare sector. One of the areas in which massive change has been taking place is surgery, with surgical robots helping to improve patient outcomes in
Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript
12:33pm, Wednesday, 24'th Sep 2025
Medtronic plc (NYSE:MDT ) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're g
Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?
10:01am, Wednesday, 24'th Sep 2025
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.
1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today
05:54am, Monday, 22'nd Sep 2025
Medtronic (MDT -0.68%) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger results
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
08:00am, Friday, 19'th Sep 2025
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
12:31pm, Thursday, 18'th Sep 2025
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic: Buy This Dividend Aristocrat While It's Good Value
11:59am, Wednesday, 17'th Sep 2025
Medtronic remains a Buy for long-term investors, offering steady growth, durable income, and an attractive valuation below historical averages. MDT delivered solid fiscal Q1 2026 results, with 8.4% re
1 Reason Every Investor Should Know About Medtronic (MDT)
09:45am, Wednesday, 17'th Sep 2025
The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite a
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
05:41pm, Monday, 15'th Sep 2025
GALWAY, Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Off
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
09:00am, Monday, 15'th Sep 2025
Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today GALW
